KAPA
Kairos Pharma·AMEX
--
--(--)
--
--(--)
KAPA Filings
Filing Date
Form Description
Form Type
2026-04-01
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-01 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-01
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-01 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-31
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-31 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-02
Form 8-K - Current report
Key Events
2026-03-02 · Key Events
Form 8-K - Current report
2026-02-26
Form 8-K - Current report
Key Events
2026-02-26 · Key Events
Form 8-K - Current report
2026-01-26
Form EFFECT - Notice of Effectiveness
2026-01-26 ·
Form EFFECT - Notice of Effectiveness
2026-01-21
Form CORRESP - Correspondence
SEC Inquiries
2026-01-21 · SEC Inquiries
Form CORRESP - Correspondence
2026-01-15
Form UPLOAD - SEC-generated letter
SEC Inquiries
2026-01-15 · SEC Inquiries
Form UPLOAD - SEC-generated letter
2026-01-13
Form S-3 - Registration statement under Securities Act of 1933
2026-01-13 ·
Form S-3 - Registration statement under Securities Act of 1933
2025-12-23
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-23 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
